Placido Maria Mazzone

Plain English
This study looked at how to make MRI procedures faster and easier for patients with heart devices like pacemakers. Researchers found that by using automatic technology for switching MRI modes, they could reduce the number of necessary device checks by about 25-30%, improving efficiency and saving staff time. This is important because it means more patients can get MRI scans safely without delaying the process. Who this helps: This benefits patients with heart devices who need MRI scans.

Plain English
This study examined the changes in the heart's atria that lead to a condition called atrial fibrillation (AF). Researchers found that specific electrical and structural changes in the heart contribute to AF, making it more likely for patients to experience recurring symptoms. For example, they identified low-voltage areas in the heart that indicate damaged tissue, which are linked to higher rates of AF returning after treatments. Understanding these changes helps doctors better manage AF by using targeted therapies, like pulmonary vein isolation, to improve patient outcomes. Who this helps: This helps patients with atrial fibrillation and their doctors.

Plain English
The study compared two treatment options for people suffering from moderate-to-severe functional mitral regurgitation (a heart valve problem) — one group received a procedure called transcatheter edge-to-edge repair (TEER) along with medication, while the other group received medication alone. The findings showed that patients receiving TEER plus medication had a 28% lower risk of dying or being hospitalized due to heart failure over two years compared to those who only received medication. This is important because it suggests that combining TEER with standard treatment can lead to better long-term outcomes for heart failure patients. Who this helps: This helps patients with functional mitral regurgitation and their doctors by offering a potentially more effective treatment option.

Plain English
This study examined the effects of a procedure called Left Atrial Appendage Closure (LAAC) on patients who experienced a certain type of stroke (cardioembolic stroke) while taking blood thinners. Out of 109 patients, those who received the LAAC procedure had a lower rate of death, recurrence of stroke, and major bleeding—40% of patients who received LAAC versus 60% who only continued on blood thinners. These findings suggest that the combination of LAAC and blood thinners leads to better long-term health outcomes in these patients. Who this helps: Patients with cardioembolic stroke who struggle with current blood thinner treatments.

Plain English
This study looked at how the medication Sacubitril/Valsartan affects heart function in patients with heart failure. Researchers found that after three months of treatment, patients had a slight increase in heart rate variability and a decrease in their average heart rates, with the average heart rate dropping from 73.2 beats per minute (bpm) to 69.9 bpm. This is important because better heart function can lead to improved health outcomes for patients with heart failure. Who this helps: Patients with heart failure, particularly those with reduced heart function.

Plain English
This study focused on a lung condition called diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH), which often looks like asthma but actually involves abnormal growth of specific lung cells. Researchers found that many patients have varied symptoms, such as chronic cough and difficulty breathing, and there are differences in how their lung function is affected. Increasing awareness and collaboration among different medical specialists is crucial to improve diagnosis and treatment for this condition. Who this helps: This helps doctors and patients affected by lung disorders.

Plain English
This study looked at whether a bacteria called Mycobacterium avium subsp. paratuberculosis (MAP), linked to a disease in livestock and potential health concerns in humans, survives during the making of Pecorino cheese. It was found that the cheesemaking process can reduce the amount of MAP by about 90% after 60 to 90 days, which helps make the cheese safer to eat. However, since the bacteria can still be present, it is recommended to pasteurize the milk at 72°C for 25 seconds if it comes from farms with known cases of the disease. Who this helps: This benefits cheese producers and consumers who want safer dairy products.

Plain English
This study explored how often hidden cancer in the opposite side of the chest (contralateral hilar lymph nodes) is detected in patients with non-small cell lung cancer (NSCLC) using a specific technique called EBUS-TBNA. Among 516 patients, only 5 (0.97%) had cancerous lymph nodes on the opposite side, mainly those already showing evidence of advanced disease on scans. The findings suggest that patients with earlier stages (N0/N1) may not need extra testing on the opposite side, while those with more advanced stages (N2/N3) should. Who this helps: This helps doctors decide when additional testing is necessary for lung cancer patients.

Plain English
This study looked at how levels of a protein called factor XI (FXI) change in patients who have a heart attack (specifically STEMI) and receive a procedure to open their blocked arteries. The researchers found that FXI levels increased by about 34% from the time the patients were admitted to when they were discharged, from an average of 0.865 to 1.161 IU/mL. This matters because understanding these changes could lead to better treatments that help prevent dangerous blood clots in heart attack patients. Who this helps: Patients experiencing STEMI and their doctors.

Plain English
This study looked at a new heart device called the extravascular implantable cardioverter-defibrillator (EV-ICD), designed to prevent sudden heart death while reducing complications that can occur with other types of heart devices. At a busy hospital, they treated 10 patients with this device over 8 months and found it helpful in improving heart safety without the common problems associated with traditional devices. This matters because it offers a new, safer option for patients at risk of dangerous heart rhythms. Who this helps: This helps patients at risk of sudden cardiac death.

Plain English
This study focused on lipoprotein(a), or Lp(a), which is a genetic factor linked to a higher risk of heart disease. Researchers found that Lp(a) is much more harmful than other cholesterol types—about 5 to 6 times more atherogenic than LDL cholesterol—and that reducing Lp(a) can significantly lower cardiovascular risks. Testing and treating high Lp(a) levels could help prevent many heart-related issues in patients at risk. Who this helps: This benefits patients at risk for heart disease, particularly those with high Lp(a) levels.

Plain English
This study looked at a new method for treating a heart condition called paroxysmal atrial fibrillation (PAF) using a standardized procedure that involved advanced technology. The researchers found that this method successfully isolated problematic heart areas in 100% of cases, with only 9% of patients experiencing a return of symptoms after one year, and 12% after two years. This is significant because it shows that the new approach is efficient and maintains patient safety. Who this helps: This helps patients with paroxysmal atrial fibrillation seeking effective treatment.

Plain English
This study looked at a heart condition called arrhythmia-induced cardiomyopathy (AIC), where irregular heartbeats weaken the heart's pumping ability. It found that after catheter ablation—a procedure to fix these irregular beats—about 70% of patients showed improvement in their heart function. Identifying reliable predictors of who will benefit from this treatment is important because it can help doctors make better decisions for their patients. Who this helps: Patients with arrhythmia-induced cardiomyopathy.

Plain English
This research looked at how Italian heart doctors use leadless pacemakers, small devices that help regulate heartbeats without wires. Out of 92 doctors surveyed, 59% said they implanted fewer than 20 leadless pacemakers each year, mainly for patients with specific health issues like a high risk of infection. The main barriers to using more leadless pacemakers included high costs and technical limitations, but the procedure itself was generally quick and safe, mostly performed with just local anesthesia. Who this helps: This benefits heart patients who may need a pacemaker but are at risk for complications with traditional wired devices.

Plain English
This study examines a heart condition called myocardial infarction with nonobstructive coronary arteries (MINOCA), where heart damage occurs without a major blockage in the arteries. Researchers found that MINOCA affects women more than men, and it can be caused by various issues such as blood vessel spasms or clots. Understanding and properly diagnosing MINOCA is crucial for treatment, as current methods are based on strategies for other heart diseases. Who this helps: This helps patients, particularly women experiencing heart problems, and their doctors.

Plain English
This study looked at how well a new sedation method using two medications, Dexmedetomidine and Midazolam, worked for patients undergoing a heart procedure called left atrial appendage closure (LAAC). Out of 100 patients, all successfully completed the procedure, with 94 able to receive guidance using this sedation method. Importantly, there were no complications related to the sedation, and no one needed to switch to general anesthesia. Who this helps: This benefits patients needing heart procedures by providing a safer and more comfortable experience.

Plain English
This study looked at how to better understand the risk of serious heart rhythm problems in people with arrhythmogenic cardiomyopathy, a condition where heart tissue is replaced by scar tissue, which can lead to dangerous heart rhythms and sudden cardiac death. The researchers reviewed existing studies and found that accurately identifying these risks is crucial for managing patients, especially since many affected individuals may not show symptoms until it's too late. This is important because improving risk assessment can help prevent sudden deaths and better guide treatment plans. Who this helps: This benefits patients with arrhythmogenic cardiomyopathy and their doctors.

Plain English
This study looked at 1,587 patients admitted for acute coronary syndrome (ACS) to a hospital in Milan, focusing on those who experienced life-threatening heart rhythm problems at the start (called ventricular arrhythmias). It found that 4.6% had these dangerous rhythms, and they faced much higher risks: 23% of these patients died in the hospital, compared to just 4% of those without arrhythmias. The results highlight the need for close monitoring of patients with arrhythmic onset in the first month and a half after their heart issue, as they are at a greater risk of severe complications and death during that time. Who this helps: This benefits patients with acute coronary syndrome and their doctors by emphasizing the importance of monitoring those who present with arrhythmias.

Plain English
The Watch the Spot Trial examined how to best monitor small lung nodules found by accident or during screening in nearly 35,000 participants. The study compared two monitoring approaches: one that was more intensive and one that was less. It found that over 40% of the nodules were very small (4 mm or less), suggesting many of these nodules might not be very concerning, yet important details about the nodules were often missing from medical reports, highlighting a need to improve reporting practices. Who this helps: This benefits patients with small lung nodules by ensuring they receive appropriate monitoring and better information about their condition.

Plain English
This study looked at how epilepsy in pregnant women affects their babies and whether medications taken during pregnancy play a role. Researchers found that women with epilepsy had higher risks of preterm birth, cesarean sections, and neonatal problems; specifically, those taking seizure medications had even greater risks, with a 47% higher chance of preterm birth and a 54% higher chance of needing neonatal intensive care. These findings highlight the importance of careful management and communication between doctors who specialize in pregnancy and those who treat epilepsy to improve outcomes for mothers and babies. Who this helps: This helps pregnant women with epilepsy and their healthcare providers.

Plain English
This study looked at whether stopping one medication in a dual antiplatelet therapy (DAPT) regimen early could help patients with ST-elevation myocardial infarction (STEMI) avoid major bleeding without increasing their risk of heart complications. The research included eight trials with over 10,000 patients and found that shorter DAPT significantly cut major bleeding incidents in half, while heart events remained similar between those on shorter therapy and those on the standard 12-month treatment. This is important because it suggests that patients could have a safer treatment option after a heart attack without losing protection against further heart issues. Who this helps: This helps patients recovering from heart attacks and their doctors in choosing safer treatment plans.

Plain English
This study looked at patients with Brugada syndrome, a heart condition that can lead to sudden death, and compared those who experienced a type of abnormal heart rhythm known as monomorphic ventricular tachycardia (MVT) with those who had ventricular fibrillation (VF). Among 793 patients, 54 had MVT, which occurred at an average age of about 48 years, while VF was seen in a total of 47 episodes in this group. The study found that MVT patients generally had longer-lasting heart rhythm issues and a wider area of heart muscle affected, which highlights the differences in how these two arrhythmias present and develop. Who this helps: This helps patients with Brugada syndrome and their doctors by providing insights into their risk profiles and potential treatment options.

Plain English
Researchers studied how to improve the quality of lung cancer screening over the last ten years. They identified eight key components that should be part of any lung cancer screening program to ensure it works well and helps patients without causing unnecessary harm. This is important because better screening can catch lung cancer earlier, which increases the chances of successful treatment. Who this helps: This helps patients at risk of lung cancer and the doctors who screen them.

Plain English
This study focuses on a type of heart rhythm problem called premature ventricular contractions (PVCs), specifically those that start in a difficult-to-reach part of the heart known as the left ventricular summit (LVS). The researchers found that these PVCs have unique patterns on heart tests, which can help doctors locate the source and decide on the best treatment approach. Recognizing and treating these arrhythmias is important because it can lead to better management of patients' heart health. Who this helps: This helps patients experiencing irregular heartbeats, particularly those with PVCs from the left ventricular summit.

Plain English
This study looked at a treatment called Excimer laser coronary atherectomy (ELCA) for patients with difficult heart blockages. Out of 320 patients, 97% had a successful procedure, and only 1.2% experienced serious complications while in the hospital. Long-term, about 94.7% of patients avoided serious health issues related to their hearts over about two years. Who this helps: This benefits patients with complex coronary diseases and their doctors managing high-risk heart conditions.

Plain English
This study focused on understanding the role of a protein called HUNK in the progression of gastric cancer. The researchers found that HUNK helps cancer cells grow more rapidly and stay alive by affecting certain cell processes. When HUNK was removed, the cancer cells and patient samples showed decreased survival, and the study also revealed that HUNK increases levels of a cancer marker, MUC16/CA-125. These insights are important because they could lead to new treatment options targeting HUNK for better management of gastric cancer. Who this helps: This benefits patients with gastric cancer and their doctors looking for more effective treatments.

Plain English
This study focused on gastric cancer (GC), a serious type of cancer that leads to many deaths due to its late diagnosis and tendency to spread. It found that cancer cells in GC can resist a type of cell death called anoikis, which normally helps stop tumor growth when cells detach from their surroundings, leading to challenges in treatment. Understanding how these processes work is important because it can help develop new therapies that are more effective for patients, ultimately improving survival rates. Who this helps: This research benefits gastric cancer patients and their doctors by highlighting new treatment possibilities.

Plain English
This study looked at a protein called CLIC2 and its role in a type of stomach cancer known as genomically stable gastric cancer. Researchers found that when CLIC2 was removed from certain immune cells called macrophages, these cells changed shape and behavior, producing more of some chemicals involved in inflammation but less of others. This matters because it shows how CLIC2 influences the immune environment in tumors, potentially aiding gastric cancer growth. Who this helps: Patients with gastric cancer and their doctors.

Plain English
This study explored the role of inflammation in heart disease and looked at various treatments to reduce inflammation in patients with cardiovascular disease (CVD). Researchers found that traditional treatments, like colchicine, can lower heart-related problems, but new therapies targeting inflammation, such as monoclonal antibodies, haven't yet been approved for regular use. This matters because reducing inflammation could significantly improve treatment outcomes for heart disease patients. Who this helps: Patients with cardiovascular disease.

Plain English
This study examined how the immune systems of buffaloes and cattle respond to bovine tuberculosis (BTB), a disease that affects both animals and humans. Researchers analyzed blood samples from 35 buffaloes and 10 cattle to see how their immune cells (CD4T lymphocytes) produced specific signaling molecules after exposure to the disease. They found that while both species showed similar immune responses, certain differences were noted, including specific cell types that indicated infection status. This research is important because understanding these immune responses can help develop better disease control strategies for both livestock and human health. Who this helps: This helps veterinarians and livestock farmers manage and prevent bovine tuberculosis in buffaloes and cattle.

Plain English
This study compared two methods of viewing the heart during a procedure to close off a part of the heart called the left atrial appendage, which can reduce the risk of stroke. Researchers found that using a method called transesophageal intracardiac echocardiography (TE-ICE) had a technical success rate of 98%, similar to the standard method, transesophageal echocardiography (TEE), which had a success rate of 96%. Importantly, both methods had low rates of complications, making TE-ICE a good alternative that avoids the need for general anesthesia, especially benefiting older and more fragile patients. Who this helps: Patients undergoing heart procedures, particularly the elderly and those with health complications.

Plain English
This study looked at a 45-year-old man with severe mitral regurgitation, where the heart's mitral valve doesn't close properly, due to a serious heart issue. Since surgery wasn't a good option for him, doctors used a method called mitral transcatheter edge-to-edge repair (M-TEER) and placed two MitraClips to fix the valve, resulting in only mild leakage afterward and a pressure of 5 mmHg in the valve area. This is important because it shows that M-TEER can be a viable treatment for younger patients who can't have traditional surgery. Who this helps: This helps patients with severe mitral regurgitation who are too young or high-risk for surgery.

Plain English
This study looked at how inflammation after a heart attack (acute myocardial infarction) affects the risk of future heart problems. Researchers found that ongoing inflammation is a stronger predictor of bad outcomes, like recurrent heart attacks or death, compared to traditional risk factors like cholesterol levels. Understanding and managing this inflammation could lead to better treatments and improved survival rates for patients after a heart attack. Who this helps: This helps patients recovering from heart attacks.

Plain English
This study looks at how heart disease affects pregnant women and finds that cardiovascular disease during pregnancy is a leading cause of complications and deaths, making up about one-third of pregnancy-related deaths globally. It highlights the importance of understanding different heart conditions in pregnancy, such as heart failure and high blood pressure, and the need for better management strategies to protect both mothers and their babies. Improving cooperation between heart specialists and obstetricians can help ensure women get the best care during and after pregnancy. Who this helps: This helps pregnant women at risk of heart disease and their healthcare providers.

Plain English
This study looked at a heart condition called mitral annular disjunction (MAD) and its link to life-threatening irregular heartbeats in high-risk patients. Researchers followed five patients with MAD who received implantable devices to prevent arrhythmias from January 2020 to April 2025. They found that four of these patients experienced serious heart rhythm issues, even in cases where no physical signs of heart damage were detected, highlighting that the risk of arrhythmias may exist before any visible problems appear. Who this helps: This research helps doctors better understand and manage patients at risk for dangerous heart rhythms.

Plain English
The study examined the long-term outcomes of patients undergoing repeat procedures for narrowed arteries in their hearts, comparing those who had the same artery treated again (target-vessel revascularization) with those who had a different artery treated (nontarget-vessel revascularization). Among 299 patients, 37.3% of those treated for the same artery experienced serious heart events after three years, compared to 28.8% of those treated for a different artery. This research highlights that many patients face a high risk of future heart problems after these procedures, emphasizing the need for better imaging techniques and more aggressive treatment plans to reduce these risks. Who this helps: This helps patients with chronic coronary syndrome and their doctors in managing ongoing heart health risks.

Plain English
This study looked at patients with a specific type of irregular heartbeat (atrial fibrillation) who had a stroke despite taking blood-thinning medication. Out of 2,234 patients who underwent a procedure to close a small part of the heart called the left atrial appendage, only 4% had another stroke within two years, which is much lower than the expected stroke rate in similar patients. This finding suggests that the heart procedure may provide additional protection against future strokes for these high-risk patients. Who this helps: This benefits patients with atrial fibrillation who have experienced a stroke and their doctors.

Plain English
This study looked at how effective and safe a short 13Fr mechanical sheath can be for removing cardiac device leads in patients. Out of 202 patients treated, 97% had a successful extraction of their leads, and serious complications occurred in only 2%. This is important because it shows that using this new type of sheath can make lead removal safer and more efficient, which is vital for patients who need this procedure. Who this helps: This helps patients with cardiac devices and the doctors performing their lead extractions.

Plain English
This study looked at how well cerebral protection devices work to prevent strokes during heart procedures in patients with blood clots in the heart. Researchers tracked 65 patients who either had a left atrial appendage occlusion or other heart procedures, finding no strokes occurred during these procedures, though there were some minor complications related to the devices. This is important because it shows that these high-risk heart interventions can be done safely, which could improve outcomes for patients with blood clots. Who this helps: This helps patients with heart problems and blood clots who need these procedures.

Plain English
This study looked at a new method called the "No-cut technique" for removing heart device leads from patients, aiming to see if it could improve success rates and reduce complications. Researchers found that this technique allowed for a higher rate of complete lead removal (97% compared to 92% with the old method), less lead fragmentation (4% vs 11%), and shorter procedure times, all without increasing complications. These findings are significant because improving the lead extraction process can help patients recover better and faster. Who this helps: Patients undergoing lead extraction procedures.